CardioFocus® Announces Initial Commercial Procedures Following US FDA Approval of HeartLight® X3 System for the Treatment of Atrial Fibrillation
SEE MORE
ESC
Aug 29 – Sept 2, 2020
Amsterdam, Netherlands
